First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis.

Name: First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis.
Author: Renders, Lutz

First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis. — المؤلف: Renders, Lutz — PloS one 20200106

المؤلف: Renders, Lutz
النشر: PloS one 20200106
الوصف: e0212023 p.
الموضوعات: Adult؛ Double-Blind Method؛ Female؛ Half-Life؛ Healthy Volunteers؛ Hepcidins؛ Humans؛ Infusions, Intravenous